| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/01/2022 | Kintara Therapeutics, Inc. | DMPI | Grant | Option (right to buy) | 1.2M | $0.18 | $211k | | 08/01/2022 |
| 08/01/2022 | Kintara Therapeutics, Inc. | DMPI | Grant | Common Stock | 400.1k | $0.00 | $0 | | 08/01/2022 |
| 02/15/2022 | Kintara Therapeutics, Inc. | DMPI | Purchase | Common Stock | 55k | $0.47 | $25.8k | | 02/15/2022 |
| 11/08/2021 | Kintara Therapeutics, Inc. | DMPI | Grant | Options (Right to Buy) | 3.5M | $0.96 | $3.4M | | 11/08/2021 |
| 09/22/2021 | Kintara Therapeutics, Inc. | DMPI | Grant | Options (Right to Buy) | 100k | $1.24 | $124k | | 09/22/2021 |
| 06/22/2021 | Kura Oncology, Inc. | KURA | Grant | Option to purchase common stock | 23k | $21.54 | $495.4k | | 06/22/2021 |
| 09/15/2020 | Kintara Therapeutics, Inc. | DMPI | Grant | Options (Right to Buy) | 120k | $1.70 | $204k | | 09/15/2020 |
| 06/26/2020 | Kintara Therapeutics, Inc. | DMPI | Grant | Options (Right to Buy) | 39.6k | $0.61 | $24.1k | | 06/26/2020 |
| 06/24/2020 | Kura Oncology, Inc. | KURA | Grant | Option to purchase common stock | 23k | $17.97 | $413.3k | | 06/24/2020 |
| 12/19/2019 | HERON THERAPEUTICS, INC. /DE/ | HRTX | Grant | Employee Stock Option (Right to Buy) | 100k | $25.02 | $2.5M | | 12/19/2019 |
| 09/12/2019 | Aravive, Inc. | ARAV | Grant | Stock Option | 7.5k | $5.77 | $43.3k | | 09/12/2019 |
| 09/05/2019 | Kintara Therapeutics, Inc. | DMPI | Grant | Options (Right to Buy) | 39.6k | $0.61 | $24.1k | | 09/05/2019 |
| 09/05/2019 | Kintara Therapeutics, Inc. | DMPI | Grant | Options (Right to Buy) | 35.4k | $0.61 | $21.6k | | 09/05/2019 |
| 06/25/2019 | Kura Oncology, Inc. | KURA | Grant | Option to purchase common stock | 13k | $19.55 | $254.2k | | 06/25/2019 |
| 04/30/2019 | Kintara Therapeutics, Inc. | DMPI | Disposition | Performance Stock Units | 200k | $0.00 | $0 | | 04/30/2019 |
| 01/03/2019 | Aravive, Inc. | ARAV | Grant | Stock Option | 7.5k | $0.00 | $0 | | 01/03/2019 |
| 01/03/2019 | Aravive, Inc. | ARAV | Grant | Stock Option | 4.7k | $0.00 | $0 | | 01/03/2019 |
| 01/03/2019 | Aravive, Inc. | ARAV | Grant | Stock Option | 7.5k | $3.69 | $27.7k | | 01/03/2019 |
| 01/03/2019 | Aravive, Inc. | ARAV | Grant | Stock Option | 4.7k | $3.69 | $17.3k | | 01/03/2019 |
| 12/15/2018 | HERON THERAPEUTICS, INC. /DE/ | HRTX | Grant | Employee Stock Option (Right to Buy) | 71k | $24.97 | $1.8M | | 12/15/2018 |
| 11/08/2018 | Kintara Therapeutics, Inc. | DMPI | Grant | Options (Right to Buy) | 40k | $0.61 | $24.4k | | 11/08/2018 |
| 07/02/2018 | HERON THERAPEUTICS, INC. /DE/ | HRTX | Sale | Common Stock | 28.9k | $38.15 | $1.1M | | 07/02/2018 |
| 07/02/2018 | HERON THERAPEUTICS, INC. /DE/ | HRTX | Sale | Common Stock | 1.1k | $38.80 | $41.1k | | 07/02/2018 |
| 07/02/2018 | HERON THERAPEUTICS, INC. /DE/ | HRTX | Exercise | Employee Stock Option (Right to Buy) | 30k | $15.30 | $459k | | 07/02/2018 |
| 06/07/2018 | Kura Oncology, Inc. | KURA | Grant | Option to purchase common stock | 13k | $16.35 | $212.6k | | 06/07/2018 |
| 04/30/2018 | HERON THERAPEUTICS, INC. /DE/ | HRTX | Other (acquisition) | Common Stock | 744 | $13.22 | $9.8k | | 07/02/2018 |
| 04/13/2018 | Kintara Therapeutics, Inc. | DMPI | Grant | Performance Stock Units | 200k | $0.00 | $0 | | 04/13/2018 |
| 04/13/2018 | Kintara Therapeutics, Inc. | DMPI | Grant | Options (Right to Buy) | 36k | $1.06 | $38.2k | | 04/13/2018 |
| 12/18/2017 | HERON THERAPEUTICS, INC. /DE/ | HRTX | Grant | Employee Stock Option (Right to Buy) | 56.7k | $17.00 | $963.3k | | 12/18/2017 |
| 11/14/2017 | CombiMatrix Corp | CBMX | Disposition | Common Stock | 2k | $0.00 | $0 | | 11/14/2017 |
| 11/14/2017 | CombiMatrix Corp | CBMX | Other | Common Stock | 6.6k | $0.00 | $0 | | 11/14/2017 |
| 11/14/2017 | CombiMatrix Corp | CBMX | Other | Warrant (Right to Buy) | 1.6k | $46.80 | $75.8k | | 11/14/2017 |
| 10/31/2017 | HERON THERAPEUTICS, INC. /DE/ | HRTX | Other (acquisition) | Common Stock | 536 | $13.05 | $7k | | 12/18/2017 |
| 06/09/2017 | Kura Oncology, Inc. | KURA | Grant | Option to purchase common stock | 10k | $8.60 | $86k | | 06/09/2017 |
| 04/02/2017 | MABVAX THERAPEUTICS HOLDINGS, INC. | MBVX | Exercise | Restricted Stock Unit | 1.5k | $0.00 | $0 | | 04/02/2017 |
|